Use of health-related quality of life in prescribing research. Part 1. Why Evaluate Health-Related Quality of Life?

Melanie Calvert, Nick Freemantle

    Research output: Contribution to journalArticle

    55 Citations (Scopus)

    Abstract

    Clinicians, regulatory authorities, and pharmaceutical companies increasingly recognize the importance of assessing the patient's perspective on the impact of disease and its treatment on their health-related quality of life (HRQoL). This article describes the importance of assessing HRQoL, particularly in patients with chronic disease, provides examples of the different types of instrument available for measuring HRQoL and considers how such assessment can aid medical-decision making. In addition we consider the potential role of HRQoL assessment in routine clinical practice, and its use in licensing and health technology appraisal.
    Original languageEnglish
    Pages (from-to)513-21
    Number of pages9
    JournalJournal of Clinical Pharmacy and Therapeutics
    Volume28
    Issue number6
    DOIs
    Publication statusPublished - 1 Dec 2003

    Fingerprint

    Dive into the research topics of 'Use of health-related quality of life in prescribing research. Part 1. Why Evaluate Health-Related Quality of Life?'. Together they form a unique fingerprint.

    Cite this